1
项与 nL-SCN2A-002 相关的临床试验Personalized Antisense Oligonucleotide Therapy for Rare Pediatric Genetic Disease: SCN2A
This research project entails delivery of a personalized antisense oligonucleotide (ASO) drug designed for a single pediatric participant with SCN2A associated developmental epileptic encephalopathy
100 项与 nL-SCN2A-002 相关的临床结果
100 项与 nL-SCN2A-002 相关的转化医学
100 项与 nL-SCN2A-002 相关的专利(医药)
100 项与 nL-SCN2A-002 相关的药物交易